COMP <GO>
NEOG vs UNH // GROSS PROFIT MARGIN
Neogen Corporation (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: NEOG 0
— UNH 10
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $12.26 (+1.16%) • MKT CAP: $2.68B
gross-margins
46.90%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEOG VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEOG | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 46.90% | 88.57% | -41.67 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -0.60% | 11.47% | -12.07 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 6.48% | -3.37 | UNH | /fcf-yield <GO> |
| Operating Margin | -2.50% | 4.82% | -7.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | -0.90% | 3.14% | -4.04 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 6.46% | -9.16 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | 3.12 | -1.67 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.6 | 59.2 | -7.60 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.68B | $368.83B | -$366.15B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEOG REV | UNH REV | NEOG GROSS % | UNH GROSS % | NEOG FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $870.4M | $447.57B | 46.9% | 88.7% | $83.2M | $16.07B |
| FY 2024 | $894.7M | $400.28B | 47.1% | 88.3% | $58.2M | $20.70B |
| FY 2023 | $924.2M | $371.62B | — | 89.6% | $35.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEOG // BETA —
UNH // BETA 0.33